What question did this study set out to answer?

To design and synthesize novel PI3K α inhibitors for cancer treatment and evaluate their biological effects.

Design, Synthesis,and Biological Evaluation of NovelPhosphoinositide 3-Kinase (PI3K) α Inhibitors towardCancer Treatment

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates novel PI3K inhibitors showing strong anticancer effects in tumor models, suggesting therapeutic potential.

To design and synthesize novel PI3K α inhibitors for cancer treatment and evaluate their biological effects.
Designed and synthesized a series of PI3K inhibitors with a specific scaffold and NO donor module.
Evaluated antiproliferative effects in vitro on various cancer cell lines including CT26 and MCF-7.
Assessed in vivo efficacy in an allograft mouse model.
Compound 5k showed strong antiproliferative activity on CT26 cells with an IC50 of 10 nM.
Inhibition of the PI3K pathway and induced apoptosis via NO release from the furoxan moiety confirmed.
Compound 5k demonstrated significant anticancer efficacy in vivo.

Zheng et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark